Sanjeev Narula - Oct 6, 2025 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role
Chief Financial & Bus. Officer
Signature
/s/ Anne Marie Cook, Attorney-in-Fact for Sanjeev Narula
Stock symbol
PHAT
Transactions as of
Oct 6, 2025
Transactions value $
$0
Form type
4
Date filed
10/7/2025, 05:25 PM
Previous filing
Apr 2, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Narula Sanjeev Chief Financial & Bus. Officer C/O PHATHOM PHARMACEUTICALS, INC., 100 CAMPUS DRIVE, SUITE 102, FLORHAM PARK /s/ Anne Marie Cook, Attorney-in-Fact for Sanjeev Narula 2025-10-07 0001820590
This filing has been restated, see here for the amended filing

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHAT Stock Option (Right to Buy) Award $0 +200K $0.00 200K Oct 6, 2025 Common Stock 200K $11.61 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest with respect to 25% of the shares of common stock on October 6, 2026, and will vest with respect to the remaining shares in equal monthly installments over the following three years, subject to the Reporting Person's continuous service to the Issuer on the applicable vesting dates.